Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells

Luigi Sironi, Anna Maria Calvio, Lorenzo Arnaboldi, Alberto Corsini, Alessandro Parolari, Marc De Gasparo, Elena Tremoli, Luciana Mussoni

Research output: Contribution to journalArticle

Abstract

Previous studies have shown that angiotensin II stimulates the synthesis of plasminogen activator inhibitor-1 in cultured vascular cells, which suggests that activation of the renin-angiotensin system may impair fibrinolysis. We have investigated the effects of angiotensin II and of valsartan, a recently developed angiotensin II antagonist that is highly specific and selective for the angiotensin II subtype 1 receptor, on plasminogen activator inhibitor-1 secretion by smooth muscle cells isolated from rat and human vessels. Angiotensin II induced a time- and concentration-dependent increase of plasminogen activator inhibitor activity in supernatants of rat aortic cells, which reached a plateau after 6 hours of incubation with 100 nmol/L angiotensin II (2.4±0.6-fold over control value; P50 value of 21 nmol/L. Valsartan fully prevented the angiotensin II-induced increase in plasminogen activator inhibitor-1 protein and mRNA. Furthermore, angiotensin II doubled the secretion of plasminogen activator inhibitor-1 by smooth muscle cells obtained from human umbilical and internal mammary arteries, and valsartan fully prevented it. Angiotensin II did not affect the secretion of tissue plasminogen activator antigen by any of the cell systems tested. Thus, valsartan effectively inhibits angiotensin II-induced plasminogen activator inhibitor-1 secretion without affecting that of tissue plasminogen activator in arterial rat and human smooth muscle cells.

Original languageEnglish
Pages (from-to)961-966
Number of pages6
JournalHypertension
Volume37
Issue number3
Publication statusPublished - 2001

Keywords

  • Angiotensin II
  • Fibrinolysis
  • Muscle, smooth
  • Plasminogen
  • Receptors, angiotensin
  • Valsartan

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells'. Together they form a unique fingerprint.

  • Cite this